Linear Ablation Versus Focal Ablation of Complex Fractionated Atrial Electrograms in Persistent Atrial Fibrillation
NCT ID: NCT01088126
Last Updated: 2018-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2010-01-31
2017-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Benefits of Additional Complex Fractionated Atrial Electrogram Targeted Catheter Ablation for Longstanding Persistent Atrial Fibrillation
NCT02175043
Evaluation of Proper Radiofrequency Catheter Ablation Strategy for the Patients Who Were Changed to Paroxysmal Atrial Fibrillation From Persistent Atrial Fibrillation
NCT02176616
Line Versus Spot Ablation in Persistent Atrial Fibrillation
NCT00196157
Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Prospective Randomized Study
NCT02171364
Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation
NCT00296166
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Focal ablation
PV isolation + CFAE-targeted focal ablation
radiofrequency catheter ablation
radiofrequency catheter ablation, NavX system
Linear ablation
PV isolation + CFAE-guided linear ablation
radiofrequency catheter ablation
radiofrequency catheter ablation, NavX system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radiofrequency catheter ablation
radiofrequency catheter ablation, NavX system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* persistent atrial fibrillation
* candidates for AF ablation based on AF that is symptomatic and refractory to at least one antiarrhythmic medication
* at least one episode of AF must have been documented by ECG or Holter within 12 months of randomization in the trial
* continuous anticoagulation with warfarin (INR 2-3) for \>4 weeks prior to the ablation
* patients must be able and willing to provide written informed consent to participate in the clinical trial
* left atrial thrombus on TEE prior to procedure
* contraindications to systemic anticoagulation with heparin or coumadin
* previously undergone atrial fibrillation ablation
* patients who are or may potentially be pregnant
Exclusion Criteria
* patients with AF felt to be secondary to an obvious reversible cause
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University Anam Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Korea University Anam Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young-Hoon Kim, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Korea University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Korea University Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AN09239
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.